VistaPath Biosystems, Inc. — Form D/A
VistaPath Biosystems, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2022-06-21. The offering totals $7.4M, of which $7.4M was reported sold. Industry: Other Technology.
Offering
- Filed: 2022-06-21
- Form: D/A
- Accession: 0001782343-22-000003
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $7.4M
- Amount sold: $7.4M
- Investors: 35
- Date of first sale: 2022-01-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-432899
Issuer
- Name: VistaPath Biosystems, Inc.
- CIK: 0001782343
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1166 MASSACHUSETTS AVE, CAMBRIDGE, MA, 02139
- Phone: 9173017571
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Benjamin Burley | Director | Cambridge, MA |
| Benjamin Burley | Executive Officer | Cambridge, MA |
| Timothy Spong | Director | Cambridge, MA |
| Timothy Spong | Executive Officer | Cambridge, MA |
| Burley Benjamin | Director | Cambridge, MA |
| Burley Benjamin | Executive Officer | Cambridge, MA |
| Spong Timothy | Director | Cambridge, MA |
| Spong Timothy | Executive Officer | Cambridge, MA |
Other filings by this issuer (7)
More